 | • レポートコード：QYR9ST13926 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ガバペンチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、タブレットに、用途別には、癲癇、神経因性疼痛、レストレスレッグス症候群、その他にセグメント区分し、ガバペンチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ガバペンチンの世界市場概要 ・ガバペンチンの製造コスト構成分析 ・ガバペンチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ガバペンチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ガバペンチンのセグメント分析（種類別） （カプセル、タブレット） ・ガバペンチンのセグメント分析（用途別） （癲癇、神経因性疼痛、レストレスレッグス症候群、その他） ・ガバペンチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Pfizer、Depomed、TEVA、Mylan、Arbor Pharma、Novartis、Apotex、Sun Pharmaceutical、Aurobindo Pharma、Intas、Amneal、Marksans Pharma、Glenmark、Alkem、Jiangsu Enhua、Jiangsu Hengrui、Sailike） ・ガバペンチンの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
The global Gabapentin market was valued at 1430 million US$ in 2018 and will reach 1630 million US$ by the end of 2025, growing at a CAGR of 1.8% during 2019-2025.
This report focuses on Gabapentin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gabapentin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gabapentin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gabapentin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Depomed
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Capsule
Tablet
Segment by Application
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Table of Contents
Executive Summary
1 Industry Overview of Gabapentin
1.1 Definition of Gabapentin
1.2 Gabapentin Segment by Type
1.2.1 Global Gabapentin Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Segment by Applications
1.3.1 Global Gabapentin Consumption Comparison by Applications (2014-2025)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Global Gabapentin Overall Market
1.4.1 Global Gabapentin Revenue (2014-2025)
1.4.2 Global Gabapentin Production (2014-2025)
1.4.3 North America Gabapentin Status and Prospect (2014-2025)
1.4.4 Europe Gabapentin Status and Prospect (2014-2025)
1.4.5 China Gabapentin Status and Prospect (2014-2025)
1.4.6 Japan Gabapentin Status and Prospect (2014-2025)
1.4.7 Southeast Asia Gabapentin Status and Prospect (2014-2025)
1.4.8 India Gabapentin Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gabapentin
2.3 Manufacturing Process Analysis of Gabapentin
2.4 Industry Chain Structure of Gabapentin
3 Development and Manufacturing Plants Analysis of Gabapentin
3.1 Capacity and Commercial Production Date
3.2 Global Gabapentin Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Gabapentin
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Gabapentin Production and Capacity Analysis
4.2 Gabapentin Revenue Analysis
4.3 Gabapentin Price Analysis
4.4 Market Concentration Degree
5 Gabapentin Regional Market Analysis
5.1 Gabapentin Production by Regions
5.1.1 Global Gabapentin Production by Regions
5.1.2 Global Gabapentin Revenue by Regions
5.2 Gabapentin Consumption by Regions
5.3 North America Gabapentin Market Analysis
5.3.1 North America Gabapentin Production
5.3.2 North America Gabapentin Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Gabapentin Import and Export
5.4 Europe Gabapentin Market Analysis
5.4.1 Europe Gabapentin Production
5.4.2 Europe Gabapentin Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Gabapentin Import and Export
5.5 China Gabapentin Market Analysis
5.5.1 China Gabapentin Production
5.5.2 China Gabapentin Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Gabapentin Import and Export
5.6 Japan Gabapentin Market Analysis
5.6.1 Japan Gabapentin Production
5.6.2 Japan Gabapentin Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Gabapentin Import and Export
5.7 Southeast Asia Gabapentin Market Analysis
5.7.1 Southeast Asia Gabapentin Production
5.7.2 Southeast Asia Gabapentin Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Gabapentin Import and Export
5.8 India Gabapentin Market Analysis
5.8.1 India Gabapentin Production
5.8.2 India Gabapentin Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Gabapentin Import and Export
6 Gabapentin Segment Market Analysis (by Type)
6.1 Global Gabapentin Production by Type
6.2 Global Gabapentin Revenue by Type
6.3 Gabapentin Price by Type
7 Gabapentin Segment Market Analysis (by Application)
7.1 Global Gabapentin Consumption by Application
7.2 Global Gabapentin Consumption Market Share by Application (2014-2019)
8 Gabapentin Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Gabapentin Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Depomed
8.2.1 Depomed Gabapentin Production Sites and Area Served
8.2.2 Depomed Product Introduction, Application and Specification
8.2.3 Depomed Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 TEVA
8.3.1 TEVA Gabapentin Production Sites and Area Served
8.3.2 TEVA Product Introduction, Application and Specification
8.3.3 TEVA Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Mylan
8.4.1 Mylan Gabapentin Production Sites and Area Served
8.4.2 Mylan Product Introduction, Application and Specification
8.4.3 Mylan Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Arbor Pharma
8.5.1 Arbor Pharma Gabapentin Production Sites and Area Served
8.5.2 Arbor Pharma Product Introduction, Application and Specification
8.5.3 Arbor Pharma Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis
8.6.1 Novartis Gabapentin Production Sites and Area Served
8.6.2 Novartis Product Introduction, Application and Specification
8.6.3 Novartis Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Apotex
8.7.1 Apotex Gabapentin Production Sites and Area Served
8.7.2 Apotex Product Introduction, Application and Specification
8.7.3 Apotex Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Sun Pharmaceutical
8.8.1 Sun Pharmaceutical Gabapentin Production Sites and Area Served
8.8.2 Sun Pharmaceutical Product Introduction, Application and Specification
8.8.3 Sun Pharmaceutical Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Aurobindo Pharma
8.9.1 Aurobindo Pharma Gabapentin Production Sites and Area Served
8.9.2 Aurobindo Pharma Product Introduction, Application and Specification
8.9.3 Aurobindo Pharma Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Intas
8.10.1 Intas Gabapentin Production Sites and Area Served
8.10.2 Intas Product Introduction, Application and Specification
8.10.3 Intas Gabapentin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Amneal
8.12 Marksans Pharma
8.13 Glenmark
8.14 Alkem
8.15 Jiangsu Enhua
8.16 Jiangsu Hengrui
8.17 Sailike
9 Development Trend of Analysis of Gabapentin Market
9.1 Global Gabapentin Market Trend Analysis
9.1.1 Global Gabapentin Market Size (Volume and Value) Forecast 2019-2025
9.2 Gabapentin Regional Market Trend
9.2.1 North America Gabapentin Forecast 2019-2025
9.2.2 Europe Gabapentin Forecast 2019-2025
9.2.3 China Gabapentin Forecast 2019-2025
9.2.4 Japan Gabapentin Forecast 2019-2025
9.2.5 Southeast Asia Gabapentin Forecast 2019-2025
9.2.6 India Gabapentin Forecast 2019-2025
9.3 Gabapentin Market Trend (Product Type)
9.4 Gabapentin Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Gabapentin Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Gabapentin
Table Global Gabapentin Production (M Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Gabapentin Production Market Share by Types in 2018
Figure Capsule Product Picture
Figure Tablet Product Picture
Table Global Gabapentin Consumption (M Units) Comparison by Applications (2014-2025)
Figure Global Gabapentin Consumption Market Share by Applications in 2018
Figure Epilepsy
Figure Neuropathic Pain
Figure Restless Legs Syndrome
Figure Others
Figure Global Gabapentin Revenue (Million USD) (2014-2025)
Figure Global Gabapentin Production (M Units) (2014-2025)
Figure North America Gabapentin Market Size (Million USD) (2014-2025)
Figure Europe Gabapentin Market Size (Million USD) (2014-2025)
Figure China Gabapentin Market Size (Million USD) (2014-2025)
Figure Japan Gabapentin Market Size (Million USD) (2014-2025)
Figure Southeast Asia Gabapentin Market Size (Million USD) (2014-2025)
Figure India Gabapentin Market Size (Million USD) (2014-2025)
Table Gabapentin Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gabapentin in 2018
Figure Manufacturing Process Analysis of Gabapentin
Figure Industry Chain Structure of Gabapentin
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Gabapentin Manufacturing Plants Distribution
Table Gabapentin Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Gabapentin Capacity (M Units) of Major Manufacturers (2014-2019)
Table Gabapentin Production (M Units) of Major Manufacturers (2014-2019)
Table Gabapentin Production Market Share of Major Manufacturers (2014-2019)
Figure Gabapentin Production Share by Manufacturers in 2018
Table Gabapentin Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Gabapentin Revenue Market Share of Major Manufacturers (2014-2019)
Figure Gabapentin Revenue Share by Manufacturers in 2018
Table Gabapentin Average Price (USD/K Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Gabapentin Production by Regions 2014-2019 (M Units)
Table Global Gabapentin Production Market Share by Regions 2014-2019
Figure Global Gabapentin Production Market Share by Regions in 2018
Table Global Gabapentin Revenue by Regions 2014-2019 (Million USD)
Table Global Gabapentin Revenue Market Share by Regions 2014-2019
Figure Global Gabapentin Revenue Market Share by Regions in 2018
Table Global Gabapentin Consumption by Regions 2014-2019 (M Units)
Table Global Gabapentin Consumption Market Share by Regions 2014-2019
Figure North America Gabapentin Production Growth Rate 2014-2019 (M Units)
Figure North America Gabapentin Revenue Growth Rate 2014-2019 (Million USD)
Table North America Gabapentin Production, Consumption Import and Export (M Units)
Figure Europe Gabapentin Production Growth Rate 2014-2019 (M Units)
Figure Europe Gabapentin Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Gabapentin Production, Consumption Import and Export (M Units)
Figure China Gabapentin Production Growth Rate 2014-2019 (M Units)
Figure China Gabapentin Revenue Growth Rate 2014-2019 (Million USD)
Table China Gabapentin Production, Consumption Import and Export (M Units)
Figure Japan Gabapentin Production Growth Rate 2014-2019 (M Units)
Figure Japan Gabapentin Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Gabapentin Production, Consumption Import and Export (M Units)
Figure Southeast Asia Gabapentin Production Growth Rate 2014-2019 (M Units)
Figure Southeast Asia Gabapentin Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Gabapentin Production, Consumption Import and Export (M Units)
Figure India Gabapentin Production Growth Rate 2014-2019 (M Units)
Figure India Gabapentin Revenue Growth Rate 2014-2019 (Million USD)
Table India Gabapentin Production, Consumption Import and Export (M Units)
Figure Global Consumption Gabapentin Market Share by Application (2014-2019)
Figure Global Value (Consumption) Gabapentin Market Share by Application (2014-2019)
Table Pfizer Gabapentin Production Sites and Area Served
Table Pfizer Gabapentin Product Introduction, Application and Specification
Table Pfizer Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Pfizer Gabapentin Production Growth Rate (2014-2019)
Table Pfizer Gabapentin Production Market Share (2014-2019)
Figure Pfizer Gabapentin Revenue Market Share (2014-2019)
Table Pfizer Gabapentin Main Business and Markets Served
Table Depomed Gabapentin Production Sites and Area Served
Table Depomed Gabapentin Product Introduction, Application and Specification
Table Depomed Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Depomed Gabapentin Production Growth Rate (2014-2019)
Table Depomed Gabapentin Production Market Share (2014-2019)
Figure Depomed Gabapentin Revenue Market Share (2014-2019)
Table Depomed Gabapentin Main Business and Markets Served
Table TEVA Gabapentin Production Sites and Area Served
Table TEVA Gabapentin Product Introduction, Application and Specification
Table TEVA Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table TEVA Gabapentin Production Growth Rate (2014-2019)
Table TEVA Gabapentin Production Market Share (2014-2019)
Figure TEVA Gabapentin Revenue Market Share (2014-2019)
Table TEVA Gabapentin Main Business and Markets Served
Table Mylan Gabapentin Production Sites and Area Served
Table Mylan Gabapentin Product Introduction, Application and Specification
Table Mylan Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Mylan Gabapentin Production Growth Rate (2014-2019)
Table Mylan Gabapentin Production Market Share (2014-2019)
Figure Mylan Gabapentin Revenue Market Share (2014-2019)
Table Mylan Gabapentin Main Business and Markets Served
Table Arbor Pharma Gabapentin Production Sites and Area Served
Table Arbor Pharma Gabapentin Product Introduction, Application and Specification
Table Arbor Pharma Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Arbor Pharma Gabapentin Production Growth Rate (2014-2019)
Table Arbor Pharma Gabapentin Production Market Share (2014-2019)
Figure Arbor Pharma Gabapentin Revenue Market Share (2014-2019)
Table Arbor Pharma Gabapentin Main Business and Markets Served
Table Novartis Gabapentin Production Sites and Area Served
Table Novartis Gabapentin Product Introduction, Application and Specification
Table Novartis Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Novartis Gabapentin Production Growth Rate (2014-2019)
Table Novartis Gabapentin Production Market Share (2014-2019)
Figure Novartis Gabapentin Revenue Market Share (2014-2019)
Table Novartis Gabapentin Main Business and Markets Served
Table Apotex Gabapentin Production Sites and Area Served
Table Apotex Gabapentin Product Introduction, Application and Specification
Table Apotex Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Apotex Gabapentin Production Growth Rate (2014-2019)
Table Apotex Gabapentin Production Market Share (2014-2019)
Figure Apotex Gabapentin Revenue Market Share (2014-2019)
Table Apotex Gabapentin Main Business and Markets Served
Table Sun Pharmaceutical Gabapentin Production Sites and Area Served
Table Sun Pharmaceutical Gabapentin Product Introduction, Application and Specification
Table Sun Pharmaceutical Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Gabapentin Production Growth Rate (2014-2019)
Table Sun Pharmaceutical Gabapentin Production Market Share (2014-2019)
Figure Sun Pharmaceutical Gabapentin Revenue Market Share (2014-2019)
Table Sun Pharmaceutical Gabapentin Main Business and Markets Served
Table Aurobindo Pharma Gabapentin Production Sites and Area Served
Table Aurobindo Pharma Gabapentin Product Introduction, Application and Specification
Table Aurobindo Pharma Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Aurobindo Pharma Gabapentin Production Growth Rate (2014-2019)
Table Aurobindo Pharma Gabapentin Production Market Share (2014-2019)
Figure Aurobindo Pharma Gabapentin Revenue Market Share (2014-2019)
Table Aurobindo Pharma Gabapentin Main Business and Markets Served
Table Intas Gabapentin Production Sites and Area Served
Table Intas Gabapentin Product Introduction, Application and Specification
Table Intas Gabapentin Production (M Units), Revenue (Million USD), Ex-factory Price (USD/K Unit) and Gross Margin (2014-2019)
Table Intas Gabapentin Production Growth Rate (2014-2019)
Table Intas Gabapentin Production Market Share (2014-2019)
Figure Intas Gabapentin Revenue Market Share (2014-2019)
Table Intas Gabapentin Main Business and Markets Served
Table Amneal Gabapentin Production Sites and Area Served
Table Marksans Pharma Gabapentin Production Sites and Area Served
Table Glenmark Gabapentin Production Sites and Area Served
Table Alkem Gabapentin Production Sites and Area Served
Table Jiangsu Enhua Gabapentin Production Sites and Area Served
Table Jiangsu Hengrui Gabapentin Production Sites and Area Served
Table Sailike Gabapentin Production Sites and Area Served
Figure Global Gabapentin Production (M Units) Growth Rate Forecast 2019-2025
Figure Global Gabapentin Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Gabapentin Sales Price (USD/K Unit) Forecast 2019-2025
Figure North America Gabapentin Production Growth Rate Forecast 2019-2025 (M Units)
Figure North America Gabapentin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Gabapentin Production Growth Rate Forecast 2019-2025 (M Units)
Figure Europe Gabapentin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Gabapentin Production Growth Rate Forecast 2019-2025 (M Units)
Figure China Gabapentin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Gabapentin Production Growth Rate Forecast 2019-2025 (M Units)
Figure Japan Gabapentin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Gabapentin Production Growth Rate Forecast 2019-2025 (M Units)
Figure Southeast Asia Gabapentin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Gabapentin Production Growth Rate Forecast 2019-2025 (M Units)
Figure India Gabapentin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (M Units) of Gabapentin by Type (2019-2025)
Table Global Consumption (M Units) of Gabapentin by Application (2019-2025)
Table Gabapentin Distributors List
Table Gabapentin Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
神経障害性疼痛管理の世界市場：市場規模・現状・予測 Neuropathic pain management refers to a way to relieve and treat neuropathic pain through various drugs or treatments.In 2018, the global Neuropathic Pain Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Thi…- てんかん薬の世界市場：市場規模・現状・予測 Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- てんかん治療の世界市場：市場規模・現状・予測 Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- てんかん治療の世界市場：市場規模・現状・予測 Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized).Neurological disorders treatment market is growing at a significant r…
- 術後疼痛管理の世界市場：市場規模・現状・予測 Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain developing into chronic pain. Mental health can affect a patient’s recovery and psychological vulnerability is predictive of severe postoperative pain. Edu…